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Endovascular aneurysm repair (EVAR) has revolutionized the
care of patients with abdominal aortic aneurysms. Several randomized
studies (Dutch Randomised Endovascular Aneurysm Management
Trial [DREAM], Open Versus Endovascular Repair Trial [OVER],
EVAR-1) have demonstrated an initial perioperative survival benefit
for EVAR patients compared with open repair. Long-term follow-up
in these studies reveals that there continues to be a need for secondary
interventions in the EVAR group at a steady annual rate. The most
extreme secondary intervention occurs when an open conversion is
required for a failure of endograft therapy.
I would like to congratulate Dr Brinster and colleagues for
sharing their experience with late open conversions for failed
EVAR. As cited in their article, open conversion can be associated
with a very high morbidity and mortality rate. They had no deaths
in their series of 21 patients that required open conversion for a
variety of reasons. Their mortality rate was zero despite 16 of the
21 patients requiring either a supraceliac or suprarenal aortic clamp
site. And, they did not have any patients develop renal failure. The
level of aortic cross-clamp that was required demonstrates the
complexity of the explant operative procedure. sAn interesting finding of this series is the timing of the open
onversion after initial EVAR therapy. The mean interval to
onversion was 33.4 months. But, the range extended to 73
onths after initial EVAR placement for the entire group. As
ndograft devices have improved over the years, the strict
urveillance paradigms that were initially utilized in clinical trials
nd early clinical practice after device approval have been min-
mized in some centers. I have always been concerned about
hanging the surveillance schedule in light of the possibility of
ate failures. This article highlights the necessity for lifelong
ndograft surveillance. In fact, five patients required emergent
pen conversion. Two of these five patients were lost to fol-
ow-up after their respective 4- and 5-year CT scans that did not
emonstrate any problems.
This well-documented open conversion experience highlights
he overall safety of the procedure in an experienced center despite
n older patient population and a more complex operation due to
he level of aortic cross-clamp. It also demonstrates that lifelong
urveillance remains a critical part of EVAR.
